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sII Structure II 
sH Structure H 
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Symbols sorted alphabetically. 
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G Gibbs energy J·mole-1 
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-1 
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-1 
W Inhibitor weight percent - 
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1. Introduction 
Natural gas industry has always noticed snow-like solid matter develops in pipelines 
used for gas transport. The movement of gas through the pipelines tends to push 
these snow-like materials together until they fuse to form plugs that may eventually 
block the pipelines [1]. Then, researchers discovered that these snow-like materials 
were natural gas hydrates that not only block the pipelines as it can be shown in 
figure 1.1, they can also endanger oil and gas production installations and the 
personnel that work in them. 
This is because hydrates may agglomerate into a plug that divides the pipe segment 
into two pressure sections, with the section upstream of the plug being under high 
pressure and the section downstream of the plug being under low pressure. A rupture 
can occur in the high-pressure section or the pressure differential may become large 
enough to propel the plug as a solid projectile thorough the pipe segment, which can 
be very dangerous, and can lead to major incidents including loss of lives [2]. 
 
Figure 1.1 Formation of gas hydrate plugged in a subsea pipeline. Picture from Petrobras (Brazil) [3] 
Natural gas hydrates are formed by water and small hydrocarbon molecules having a 
molecular diameter of less than 9 Å, under appropriate conditions of temperature and 
pressure [4]. Each of these hydrocarbon guest molecules are encage within a 
specific shape and size of cavity formed by hydrogen bonded water molecules. The 
hydrocarbon molecules, which commonly form hydrates, include methane (CH4), 
ethane (C2H6), propane (C3H8) and isobutane (C4H10) [5]. The conditions under which 
hydrates form include low temperatures (typically less than 300 K) and moderate-to-
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high pressure (typically more than 0.6 MPa) [4]. Thus from a knowledge of the 
chemical composition requirements and the thermodynamics of natural gas hydrates 
formation, the industry tries to prevent hydrates by the following ways [5, 6]: 
 Drying the natural gas (dehydration) 
 Heating the gas to a temperature above the hydrate equilibrium temperature at 
the operating pressure 
 Compressing the gas only to pressures below the equilibrium pressure at the 
operating temperature 
 Using chemical inhibitors 
Traditional chemical inhibitors such as methanol, ethylene glycol and triethylene 
glycol are referred to as thermodynamic inhibitors because they act by modifying the 
equilibrium curve such that hydrate can no longer form at the operating temperature 
and pressure [7]. One of the challenges with using these inhibitors is that they are 
required in high concentration (up to 50 wt. %) with large attendant cost [8]. 
Furthermore, the oil and gas industries continue to move into deeper waters and 
conditions are getting extreme. Because of that reasons, thermodynamic hydrate 
inhibitors show limits to these kinds of usages. 
Nowadays, newer forms of hydrate inhibitors have spread in the commercial market 
such as kinetic inhibitors and anti-agglomerants are required at much lower 
concentrations (effective at concentrations below 1 wt. % [8]). 
These forms of inhibitors, collectively referred to as low dosage inhibitors, which 
prevent hydrates from adhering together to form significantly large solids (anti-
agglomerants) or do not prevent hydrate nucleation but delay their formation (kinetic 
inhibitors) [9, 10]. 
2. State of the art 
For the successful development of this project, here are explained some of the latest 
researches done about the main topics: Kinetic hydrate inhibitors (KHIs) and Raman 
spectroscopy applications. 
Firstly, some field tests have performed to determine the potential of a range of KHIs 
under different field conditions. PVP (Polyvinylpyrrolidone) was used in three gas 
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wells and 800 m long gas line at the South-Western Wyoming field. PVP was found 
to be a suitable replacement for methanol, only if fluids are not too far from the 
hydrate region and/or the residence time (average amount of time that a particle 
spends in a particular system) is less than a few minutes. If a higher sub cooling is 
required, other KHIs should be considered [11]. 
VIMA/VCap (N-methyl-N-vinylacetamide/vinylcaprolactam) copolymer has been 
using in the West Pembina field in Alberta, Canada. The copolymer successfully 
inhibits the formation of hydrates in the oil pipeline operated by Imperial Oil 
Resources. Exxon has used the VIMA/VCap copolymer for field trials in the Gulf of 
Mexico. The copolymer was found to be compatible with various field facilities, and 
due to the lower liquid production and the copolymer dosage rate, a foaming 
tendency was not observed [11]. 
The VIMA/VCap copolymer has been used in a 4-inch flow line located in the Gulf of 
Mexico. The gas produced was mainly methane and the salinity of the brine was 6.1 
wt. %. The use of the copolymer reduced the chemical treatment cost to 40% of the 
methanol injection process. In addition, the logistics is much simplifying due to the 
low quantity of the inhibitor used. The copolymer has also been used at an oil field 
located on the northern coast of Peru. The use of the copolymer resulted in a cost 
reduction of 55% over the previously used methanol injection process. Due to the 
high flash point and low toxicity of VIMA/VCap, potential hazards were also easing. 
Unlike methanol, the copolymer is compatible with paraffin wax, which is used as a 
corrosive inhibitor, and other field chemicals. In another field application, the 
VIMA/VCap copolymer was used in a gas field in Texas resulting in a 16% saving of 
chemicals and 50% reduction of chemical volumes [11]. 
Secondly, one of the spectroscopic techniques with the highest development since 
de 80s is Raman spectroscopy [12]. This is because of its versatility and simplicity in 
the sample preparations. Some of the applications are at biomedical and 
pharmaceutical fields, because it can carry out non-destructive measurements in 
biological tissues. These ones are relating to in-vivo and in-vitro skin studies [13, 14], 
cancer identification [15], etc. It is also important in forensic fields such as explosive 
and drugs identification [16] due to the capacity of analyzing small samples 
(picomolar scale). 
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Furthermore, Raman spectroscopy has a high sensibility while measuring carbon 
bonds. That is why; this method is used at polymeric applications for the study of the 
chemical bonds, in particular to polymeric chains (monomers and polymers). In these 
cases, the information given about the crystallinity and density is helpful to the control 
of the polymeric reactions [17]. For the same reason as the last field, Raman 
spectroscopy is also very useful in nanotechnology and the study of new material 
such as carbon nanotubes and graphene [18]. 
However, what is more important in this project are the oil and gas industries, not 
only in the study of the influence of inhibitors but also in the different phases of the 
production and manufacturing of the oil and polymers [19]. Due to the ease in-line 
installation and the low cost of the analysis, Raman spectroscopy is an attractive 
option in monitoring and controlling petrol and gas industry processes. 
Through this project will be demonstrated how sensible is Raman spectroscopy to 
hydrogen bonds and the utility that this has in the study of clathrates and inhibitors 
[20, 21]. 
Nevertheless, this is not the end, because Raman spectroscopy has more 
applications on wide variety of fields like art, archaeology, geology, environmental 
protection, etc. [12]. 
2.1. Objectives 
The aims of this project were focus on the traineeship of the Raman equipment, 
acquiring the basic knowledge of Raman scattering and the ways for preventing gas 
hydrates. 
The first objective was making an identification and evaluation of the component’s 
structures of the inhibitors plotted in the Raman spectra. The identification of the 
main peaks of the spectra and the relation with the stretching gives relevant 
information about the future behavior of the inhibitors. 
However, the most relevant section is when the inhibitors are added to a sample with 
water and carbon dioxide. In these cases, the determination of the inhibitor’s 
influence of a variety of parameters and correlation between all of them reveals 
significant information about the gas hydrate formation. 
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Likewise, searching for the differences between the different behaviors of the 
inhibitors and comparing their effectiveness provide information about how the 
inhibitors work and inhibit the gas hydrate formation. 
3. Theoretical Background 
3.1. Gas Hydrates 
3.1.1. Gas hydrate structure and composition 
Natural gas hydrates (GH) are crystalline solids composed of water and gas. The gas 
molecules (guests) are trapped in water cavities (host) that are composed of 
hydrogen-bonded water molecules. Typical natural gas molecules include methane, 
ethane, propane and carbon dioxide [5]. In nature, they appear undersea in the 
continental shelves and the permafrost regions [22, 23]. 
 
Figure 3.1 Pressure versus temperature phase diagram for methane hydrates [25] 
GH are stable just at specific pressure and temperature conditions as it is shown in 
figure 3.1 where the temperature is typically less than 300K (almost ambient 
temperature) and the pressures are moderate (typically more than 0.6 MPa) [24]. In 
addition, it depends on other parameters such as the gas composition and the 
salinity of the water [24]. 
Gas hydrates are composed of approximately 85 mole% water, and therefore many 
of their properties are similar to those of ice such as physical appearance or density, 
whereas other properties contrast greatly with those of ice such as thermal 
conductivity and thermal diffusivity. 
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There are three main types of crystal structures for a gas hydrate, which are known 
as structure I (sI), structure II (sII), and structure H (sH). 
Cubic structure I predominates in the Earth’s natural environments, and contains 
small (0.4-0.55nm) guests while cubic structure II generally occurs with larger (0.6-
0.7 nm) guests in mostly man-made environments. However, hexagonal structure 
(sH) may occur in either environment (natural and man-made), but only with mixtures 
of both small and large (0.8-0.9 nm) molecules. Most hydrate science, and thus most 
applications, concentrates on structure I and II, while structure H is anecdotal 
occurrence [4]. 
 
Figure 3.2 The three common hydrate unit crystal structures [5] 
Figure 3.2 (a) shows the different cage types. The type of cage formation depends 
primarily on the size of the guest molecule. While methane fits into small and large 
cages of sI, propane is too large to fit into the large cage of sI but fit into the large 
cage of sII. Gas hydrates found in oil and gas pipelines are mainly sII because 
natural gas contains methane with small amounts of larger hydrocarbon molecules 
such as propane and isobutane [26]. Conversely, the majority of naturally occurring 
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deposits of gas hydrates is sI because they are 
composed of methane (from biogenic sources) and do 
not contain heavier hydrocarbons. Exceptions are 
thermogenic hydrate deposits that contain heavier 
hydrocarbons and therefore they formed from sII and in 
rare cases sH [5]. 
Figure3.2 (b) shows the different hydrate structures 
and their associated cage types and some of the 
principal properties of each one. Structure I consists of 
two different cages, a small pentagonal dodecahedral 
cage, denoted 512 (contains 12 pentagonal faces on 
the cage), and a large tetrakaidecahedral cage, 
denoted 51262 (contains 12 pentagonal and 2 
hexagonal faces on the cage). Structure II also 
includes the small 512 cage in addition to a large 
hexacaidecahedral cage, denoted 51264 (contains 12 
pentagonal and 4 hexagonal faces on the cage). 
Structure H is composed of the small 512 cage, a mid-
sized 435663 cage (contains 3 square, 6 pentagonal, 
and 3 hexagonal faces on the cage), and a large 
icosahedral cage, denoted 51268 (contains 12 
pentagonal and 8 hexagonal faces on the cage) [5]. 
Gas hydrate are known as non-stoichiometric 
compounds because some of the cages in the 
structure can be vacant; however, a sufficient numbers 
of cages must be occupied by guest molecules for the 
gas hydrate to be stable [5]. In all three structures, 
typically there is only one guest molecule within each cage. Moreover, at unusual 
conditions such as very high pressure (>0.1 GPa) [5], it is possible to have multiple-
cage occupancy with unusually small guests, such as hydrogen or noble gases. For 
example, hydrogen could form hydrates at very high pressure with as many as two 
occupants in the small cage and four in the large cage of hydrate sII [5]. However, 
very small guests and multiple occupancies are considered an aberration. 
Figure 3.3 Hydrate guests 
versus hydrate cavity size 
ranges [5] 
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Remarkably, when all hydrate cavities are filled, the three crystal types have similar 
concentrations of components: 85 mole% water and 15 mole% guest(s). Hydrate 
formation is most likely to take place at the interface between the bulk guest and 
aqueous phases, because the hydrate component concentrations greatly exceed the 
mutual fluid solubilities. The solid hydrate film at the interface acts as a barrier to 
prevent further contact of the bulk-fluid phases, and fluid surface renewal is required 
for continued clathrate formation [4]. 
A number of researchers have commented on the fit of the guest molecule within the 
hydrate cage. The size ratio is not absolute for each cage; instead, it occurs over a 
molecular size range, which has a number of important implications. The implication 
is that clathrate hydrates have no fixed size ratio of guest to host, as shown by the 
ranges in figure 3.3. This figure represents the types of guests that fit in a cage while 
the size is increasing and the type of structure. At the smallest structure, the only 
guests that fit on the cage are noble gases, diatomic molecules and methane. In 
structure I, the molecules inside the guests can be little carbon chains such as 
ethane or butane. It is particularly interesting to note the resulting behavior of 
molecules at cage size borders [4]. 
3.1.2. Formation and dissociation 
The freezing point of water is particularly high due to hydrogen bonds and the 
molecular arrangement in the solid phase takes regular and hexagonal shape. The 
presence of another compound in the proper conditions cause that the hydrogen 
bonds orientate over the second compound and consequently, a crystal (hydrate) 
forms. Hydrate nucleation and growth may have the same process as crystallization 
process such as precipitation of salt from solution. 
An important parameter for a quicker formation is the agitation. GH formation is 
facilitated by higher fluid velocities thus to the turbulence which unsettle the mixture 
and start the separation. The susceptible regions with higher turbulence are 
pipelines, vessels or heat exchangers [6]. 
The earliest conceptual picture for hydrate nucleation is the labile cluster mechanism. 
A labile cluster is an unstable entity that readily undergoes change. The labile cluster 
are composed of a guest molecule surrounded by 20 and 24 (cf. 512, 51262 cages of 
sI) or 20 and 28 (cf. 512, 51264 cages of sII) water molecules in the first solvation shell. 
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This model considers either nucleation to occur by the agglomeration of labile 
clusters on the liquid or the vapor side of the interface. A modification of the labile 
cluster model is based on adsorption and clustering on the vapor side of the 
interface. An alternative and more recent mechanism is the local structuring 
hypothesis that focuses on the development of guest molecules being arranged 
(ordered) in configurations similar to that in the hydrate a hydrogen-bonded water 
network [5]. 
In the interest of keeping this section short, just the labile cluster nucleation 
hypothesis will be resumed. Gas hydrate formation is a time dependent process that 
can be divided into hydrate nucleation, hydrate agglomeration and growth, and finally 
dissociation [5]. Figure 3.4 shows the process of the gas hydrate formation. At 
favorable temperature and pressure conditions, water molecules form pentagonal 
structures. When the gas is dissolved into the water, the pentagonal structures hold 
together and surround the new guests. As a result, the water creates an envelope 
around the gas molecules, which are called labile cluster. This new tridimensional 
structures are metastable and that is why they grow and disperse until they reach the 
critical size and they agglomerate forming a gas hydrate. 
 
Figure 3.4 Hydrate formation hypothesis [5] 
a. Hydrate nucleation 
Hydrate nucleation is the process that produces a small labile cluster. It is called 
hydrate nucleus. This cluster consists of water and gas molecules. It grows, 
disperses and tries to grow again because a labile cluster is unstable and ready for 
continuous changing [5]. The general formation formula of a gas hydrate is 
expressed below by equation3.1. 
𝑀(𝑔) + 𝑛𝐻2𝑂(𝑙) ↔ 𝑀 ∙ 𝑛𝐻2𝑂(𝑠)             (3. 1) 
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Where M is a natural gas molecules, n is the number of water molecules required to 
form a gas hydrate per one molecule of gas, and M·nH2O is the gas hydrate [28, 29]. 
Imperfections in pipelines, pipe elbow, valves, etc. are prone places for the initiation 
of the nucleation. Generally, interface gas-water is a vulnerable place for the 
nucleation [24]. 
b. Hydrate agglomeration and growth 
After the nucleation step, the crystal growth process occurs continuously and forms 
metastable clusters. The combination of three parameters should be considered. 
These are the kinetics of crystal growth at the surface of hydrate, mass transfer 
components to the growing surface, which is referred to the solubility equilibrium of 
the guest, and heat transfer away from the growing surface. This third parameter 
concerns to the fact that the hydrate nucleation is an exothermic reaction and 
consequently, the energy from the reaction should be removed in order to continue 
with the growth. Finally, when the crystal nucleus have the enough size, they 
agglomerates together and become a compact structure (clathrate). 
c. Hydrate dissociation 
Hydrate dissociation is an endothermic and vital process to eliminate hydrate crystal, 
which blocks pipelines in oil and gas industry. Thus, decomposition of gas hydrate to 
water and gas molecules can be successful by supplying external heat to destroy 
hydrogen bonds between water molecules and van der Waals interaction and 
between host and guest molecule [5]. There are different approaches that apply to 
mitigate a gas hydrate plug such as dehydration, heat management, and chemical 
inhibition [5, 30]. This is explained in more detail in the following section. 
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To sum up, figure 3.5 shows the hydrate labile cluster formation mechanism imposed 
on a pressure-temperature trace. From point 1, gas dissolves in water, consequently, 
the pressure is reducing linearly with temperature. There is no hydrate formation 
during 1 and 2 period, which is defined as induction time (nucleation time, induction 
period or lag time), because of metastability [5, 31].Induction time is time taken from 
entering to hydrate forming region and the onset of hydrate formation [32].Point 2 is 
the beginning of hydrate formation. Along point 2 and 3, pressure dramatically falls 
while a rapid hydrate growth takes place. This occurs until the end of growth for 
hydrate formation at point 3. Finally, when the temperature increases, hydrate 
dissociation starts simultaneously from point 3 to A. Hence, the pressure slightly 
increases at the beginning and then sharply rises until point A. This point is called the 
hydrate equilibrium temperature and pressure [5]. However, the information for the 
crystal growth rate after nucleation still being limited. 
3.1.3. Methods to prevent gas hydrates formation 
The industries can choose between four methods of hydrate prevention and control. 
These four methods are: 
1. Gas dehydration 
2. Maintaining an operating temperature higher than the hydrate equilibrium 
temperature 
3. Operating at a pressure lower than the hydrate equilibrium pressure 
4. Injecting a chemical 
inhibitor into the gas stream 
These hydrate prevention and 
control strategies may be 
implemented in isolation or in 
combination depending on the 
specific circumstances of the 
field, especially as it relates to 
practicability and economics [7]. 
Generally, the use of chemical 
inhibitors is about the most 
common [33].  Figure 3.5 Diagram of temperature versus pressure trace for 
methane hydrate formation [31] 
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This involves injecting chemicals into the gas stream. For a detailed explanation, the 
different kinds of chemical inhibitors and properties, more information is given in the 
following section. 
3.2. Inhibitors 
This section highlights the major classes of gas hydrate inhibitors. The aim of 
including this section is to introduce the readers to common types of inhibitors, their 
relative advantages and disadvantages, and to provide an understanding about the 
evaluation of the performance of inhibitors [11]. 
Mainly, it is possible to divide the types of inhibitors into three different classes 
attended by physicochemical action: thermodynamic hydrate inhibitors, anti-
agglomerates and kinetic hydrate inhibitors. 
3.2.1. Thermodynamic hydrate inhibitors (TIHs) 
The action of this kind of inhibitors corresponds with the direct relation of the 
thermodynamics on the system gas-water-hydrate. For some pressure, temperature 
and gas composition conditions, the free energy of the system reaches the minimum. 
The following thermodynamic equation3.2 describes the operation: 
∆𝐺 = ∆𝐻 − 𝑇∆𝑆            (3.2) 
Where ∆𝐻 is the enthalpic term and ∆𝑆 is the entropy that are related to the 
molecules structuration and the relative order [24]. 
The thermodynamic inhibitors disturb the hydrogen bonds of water molecules and 
consequently, the entropic term of equation 3.2 increases to a higher negative value 
and at the end, the Gibbs energy becomes higher. This means that the original 
temperature and pressure conditions are less favorable at forming gas hydrates than 
before. In other words, thermodynamic inhibitors shift the hydrate formation 
equilibrium curve to lower temperature and higher pressure [20]. Polar components 
such as alcohols or glycols form hydrogen bonds with water and interfere with the 
internal order of water molecule and therefore, the formation temperature for hydrate 
gas decreases [24]. 
Around this type of inhibitors, the most widely used is methanol (MeOH) because of 
its efficiency and low prices but glycols such as monoethylene glycol (MEG) and 
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diethylene glycol (DEG) are also employed. Finally, some inorganic salts such as 
NaCl or MgCl2 are effective inhibitors however; the corrosive problems that could 
damage the pipes restrict their usage [24]. 
A typical method to compare inhibitor’s effectiveness is subcooling, defined as the 
difference between GH formation temperature with and without inhibitor. This 
measurement can be theoretically calculated though the freeze point depression in 
aqueous solution in the presence of a non-volatile solute. The mathematical 
expression (equation3.3) for the freeze point depression (∆𝑇)can be written as 
follows: 
𝑥𝑖 =
∆𝐻𝑚𝑒𝑙𝑡𝑖𝑛𝑔∆𝑇
𝑅𝑇𝑚2
           (3.3) 
In which𝑅 is the universal gas constant, 𝑇𝑚 is the melting point temperature, 𝑥𝑖 is the 
solute (inhibitor) molar fraction and ∆𝐻𝑚𝑒𝑙𝑡𝑖𝑛𝑔 is the pure solvent melting heat. 
Hammerschmidt developed another equation (equation 3.4), which predict the effects 
of an additive addition in the hydrate formation temperature as a function of 
concentration [24]. 
∆𝑇 =
𝐾𝐻𝑊
𝑀(100 − 𝑊)
            (3.4) 
In which 𝑊 is the inhibitor weight percent in the aqueous phase, 𝑀 is the inhibitor 
molecular weight and 𝐾𝐻 is an empiric constant that depends on the inhibitor [34]. An 
inconvenience of this expression is that it can only be used for concentrations below 
30% in methanol weight and 20% in glycol weight [24]. 
KH values and molecular weights of inhibitors are given in table 3.1 [35]. 
Component Molecular weight (M) KH 
Methanol 32 2335 
Ethylene Glycol 62,07 2700 
Diethylene Glycol 106,12 4000 
Triethylene Glycol 150,17 5400 
Table 3.1 Physical constants of inhibitors 
Figure 3.6 shows the how the weight percent of THIs can shift the equilibrium curves 
(γequilibrium) to different temperatures in methane hydrates. The tendency reveals that if 
inhibitor concentration increases, the stability grade also increases. 
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Figure 3.6 Shift of the equilibrium curve of the methane-water hydrate stability using thermodynamic inhibitors [24] 
It is also important to say that to reach high stability grades is required an elevated 
inhibitor concentration (>10 wt. %). 
 
Figure 3.7 GH formation region shifts by the effect of methanol [24] 
In general, thermodynamic inhibitors modify the hydrate formation region by 
displacing it towards higher-pressure values and lower temperature values in respect 
of the non-inhibitor system.Figure3.7 shows a pressure-temperature diagram where 
the concentration of the inhibitor (MeOH) is variable and how this change the GH 
formation region [24]. 
3.2.2. Low Dosage Hydrate Inhibitors (LDHIs) 
A high number of researchers attempt to develop a new generation of chemicals 
because of the multiples THIs disadvantages: corrosion, Health, Safety and 
Environment (HSE) and high costs. The Low Dosage Hydrate Inhibitors (LDHIs) are 
the new developed inhibitors. LDHIs are divided into two main classes: Anti-
agglomerates (AAs) and Kinetic Hydrate Inhibitors (KHIs). The main differences 
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between THIs and KHIs are the lower concentration needed for KHIs and the 
mechanism of hydrate inhibition [36].At present, combinations of KHIs and AAs are 
alternatives for delaying hydrate formation and hydrate plug prevention respectively 
[36]. 
a. Anti-Agglomerates (AAs) 
Anti-Agglomerates are one of the LDHI classes. The effective concentration is lower 
than 1wt. % [37].Anti-agglomerates prevent the agglomeration of hydrate crystals into 
a large size. The development of gas hydrate formation still occurs, but the crystals 
do not plug and can be transported through the pipeline, because the size of the gas 
hydrate crystals is nanometric. However, they only work when a liquid hydrocarbon 
phase is present, i.e. crude oil or condensate.  
AAs are less independent of time and the degree of subcooling of the system 
compared to kinetic hydrate inhibitors (which are explained in more detail hereafter) 
and that is why they are used in deep-water applications [8]. 
b. Kinetic Hydrate Inhibitors (KHIs) 
Typically, kinetic hydrate inhibitors are water soluble polymers and they usually 
consist of other small organic molecules which are added for efficiency enhancement 
(synergists). KHIs generally have small cyclic amide groups as the active units as it is 
shown in figure 3.8[8, 37 and 38] and they do not affect the thermodynamic 
conditions of hydrate formation [11]. In fact, the purpose of KHIs is to delay gas 
hydrate nucleation and crystal growth [39]. 
 
Figure3.8 Kinetic Hydrate Inhibitor. Polyvynilpirrolidone (PVP) (a) Poly(N-Vinylcaprolactam) (PVCap) (b) [39] 
Several mechanisms have been proposed for the inhibition of gas hydrate formation 
by KHIs. One of the proposed mechanisms suggests that the perturbation of the 
water structure prevents the growth of hydrate particles to the critical size [7, 40]. 
Some studies suggested that the nucleation and/or crystal growth inhibition is 
achieved via adsorption on hydrate surface [41]. A third proposed mechanism 
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suggests that the polymer chains interfere with the nucleation and/or crystal growth of 
hydrates through an inhibitor-adsorption of guest molecules into the crystal lattice 
[42, 43]. 
Figure 3.9 shows one of those mechanisms. In this case, the polymeric chain is 
display in a crystal surface and the active groups are represented as black stars. 
When the critical nucleus size is achieved, the actives groups hold the nucleus (white 
stars) and consequently, the growth cannot begin. 
 
Figure 3.9 One mechanism for kinetic inhibitors [5] 
The time taken for hydrate formation in the presence of KHIs is larger than the 
residence time of gas in transport facilities [44]. This time depends on the degree of 
subcooling. As it is explained at section 3.2.1; subcooling(∆𝑇), is the temperature 
difference between the hydrate dissociation temperature and the operating 
temperature at a given pressure, and is the driving force for the hydrate formation 
[37, 45]. 
The commercial KHIs generally have maximum subcooling around 9-10°C. The main 
advantage of KHIs is the low concentration usage (1 wt. %) [45]. Furthermore, KHIs 
are cleaner and safer than THIs for the environment and consequently, they are 
widely proliferating. The main drawback of this kind of inhibitors is that they can only 
be applied in moderate subcoolings (less than 13°C) [46]. 
3.3. Foundations of Raman spectroscopy 
3.3.1. Introduction 
Raman spectroscopy is a photonic high-resolution technique, which gives in a few 
seconds the chemical and structural information of almost every kind of material or 
organic/inorganic component. For this reason, it is capable of identifying them. 
Raman spectroscopy analysis works with a scattered light test at one material when 
a monochromatic beam of light strikes the sample. 
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A little light portion is inelastically scattered and it has small frequency modifications 
that are unique from the analyzed material and independent from the incident light 
frequency. This analysis technique is used directly on the sample; this means that it 
is not necessary to prepare the sample and that it is a non-destructive and non-
invasive technique [47]. 
3.3.2. Raman Effect 
A. Smekal theoretically predicted the Raman Effect in 1923, although, it was 
experimentally demonstrated for the first time by Sir Chandrasekhar Venkata Raman 
in 1928 [48]. 
Ions and atoms are chemically attached to form molecules and crystal lattice 
structures, which are subjected to constant vibrational and rotational movements. 
These oscillations take place because of certain frequencies that depend on the 
particle weight and the dynamic behavior of the chemical bonds. Each vibrational and 
rotational movement corresponds to a concrete molecular energy value.  
The relation of the electronic, vibrational and rotational energy curves is shown in 
figure 3.10. This diagram shows that the energy difference between rotational states 
are much smaller than that of vibrational states, and the energy difference between 
vibrational states is much smaller than that of electronic states. That means that 
many vibrational states "belong" to the same electronic state, and that many 
rotational states belong to the same vibrational states. 
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Essentially, Raman spectroscopy analysis works with a monochromatic beam of light 
at a specific frequency𝜈0, which strikes a sample with indefinite properties. Most of 
the scattered light shows the same frequency as the incident light, but a minor 
fraction with a ratio 107 times lower than the incident light, suffers a modification 
because of light-sample interaction. The light, which keeps constant frequency 𝜈0 is 
called Rayleigh scattering. Additionally, the scattered light, which has two different 
frequencies, is called Raman scattering. The new frequencies +𝜈𝑟 and −𝜈𝑟 are 
Raman frequencies, which depends on the chemical nature, phase of the sample 
and the incident radiation [39]. Additionally, the difference between the incident and 
scattered frequencies (𝜈0 + 𝜈𝑟 and 𝜈0 − 𝜈𝑟) just depends on the first and second 
parameter [46]. In figure 3.11, the electronic energy diagram is described in which a 
horizontal line represents an energy state. 
 
Figure 3.11 Energy level diagram related Raman scattering 
Figure 3.10 Energy states of a molecule 
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When the incident photon energy ℎ ∙ 𝜈0 (where h is Plank constant) is bigger than the 
energy difference between two vibrational/rotational states, most of the photons go 
through the sample but a minor fraction is scattered. The scattering is caused by the 
incident photon, which induces the molecule to a transitory virtual energy state. The 
molecule leaves quickly the virtual energy state and stays in one of the allowed 
states, and simultaneously, it scattered a photon. The scattered photon frequency 
depends on the molecular transition [40]. 
On the one hand, if the result of the photon-molecule interaction is an incident photon 
with the same frequency, then it is an elastic collision owing to the fact that the 
molecule does not suffer any change. The incident photon has the same frequency 
𝜈0 and the molecule returns to the same energy level before the collision [40].This is 
called Rayleigh scattering. 
On the other hand, if the result of the photon-molecule interaction is a scattered 
photon with a different frequency, then it is an inelastic collision because of the 
energy transference between the molecule and photon. In this case, it there are two 
possibilities [40]: 
 When the frequency from the scattered photon is less than the incident is 
because the energy transfer goes from the photon to the molecule. This 
means that at the end, the molecule is at a higher state than before the 
collision. The scattered photon has a frequency 𝜈0 − 𝜈𝑟 and this case is called 
Raman Stokes scattering. 
 When the frequency from the scattered photon is higher than the incident is 
because the energy transfer goes from the molecule to the photon. This 
means that the molecule was at a higher state and after the collision, it returns 
to the fundamental state. The scattered photon has a frequency 𝜈0 + 𝜈𝑟 and 
this case is called Raman Anti-Stokes scattering. 
Raman shift (𝜈𝑟)is typically expressed in wavenumbers, which have units of inverse 
length, as this value is directly related to energy. Equation 3.5 shows the calculation 
of the Raman shift: 
𝜈𝑟 = (
1
𝜆0
−
1
𝜆1
)             (3.5) 
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Where 𝜈𝑟 is the Raman shift expressed in wavenumber, 𝜆0 is the excitation 
wavelength, and 𝜆1 is the wavelength of the scattered photon. Most commonly, the 
unit chosen for expressing wavenumber in Raman spectra is inverse centimeters 
(cm-1). Since wavelength is often expressed in units of nanometers (nm), the formula 
above can scale for this unit conversion explicitly. 
As it can be seen in figure 3.12, a spectrum is represent by a main band (Rayleigh) 
and two secondary series, which correspond to Raman Stokes and anti-Stokes on 
both sides of Rayleigh band [39]. 
 
Figure 3.12 Rayleigh, anti-Stokes and Stokes bands [49] 
At normal temperature and according to Maxwell-Boltzmann distribution energy law, 
99% of the molecules are in the less energetic vibrational state, this means that the 
probability of Raman-Stokes scattering is higher than Raman anti-Stokes scattering. 
Raman Stokes scattering is around 100 times higher than Raman anti-Stokes 
scattering [47]. 
Along the next section, the writer is going to focus just on one spectrum, in concrete, 
the water spectra, which is clearly important to comprehend the basis of this work. 
3.3.3. Raman spectrum: Liquid water 
Because the main body of the samples is water, it has a relevant importance to study 
the water Raman spectra. 
As it can be show in figure 3.13, when water is analyzed at different temperatures, 
the Raman spectra show a static point at approximately 3357 cm-1 that it is called 
isosbestic point. The scattered intensity under constant excitation power, and at a 
fixed Raman frequency, ∆?̅? cm-1 is constant and independent of the intensive 
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quantity, temperature, concentration, e.g., that gives rise to the spectral changes, for 
the pure liquid or solution studied [51]. 
 
Figure 3.13 Raman spectra of liquid water at different temperatures (a), (b) shows a magnification between the 
Raman Shift 3150 and 3500 (Isosbestic Point) 
According to the isosbestic point, it is possible to divide the spectra in two different 
sections in accordance with the strength of the hydrogen bonds. 
As figure 3.14 shows at the left side until the isosbestic point is the Strongly 
Hydrogen-Bonded (SHB), which decreases their intensity when the temperature 
increases (figure 3.13) and after the isosbestic point to the right side is Weakly 
Hydrogen-Bonded (WHB), which increases their intensity when the temperature 
increases. 
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Figure 3.14 Raman spectra (liquid water) divided into the Strongly Hydrate-Bonded and the Weakly Hydrogen-
Bonded. 
Water spectrum should be modified with the use of THI inhibitors, but not when KHIs 
are used. In these cases, while SHB area decrease and WHB area increase; and 
consequently the area below the curve changes. This difference demonstrates that is 
less likely to form gas hydrate due to the hydrogen bond strength diminution. 
It is easy to get the numerical data from the graph to obtain the result of the 
experiments. To be certainly sure, during these experimental exercises, two ways to 
calculate the relation between both sides of the spectrum were used. 
1. Direct integration of the two areas below the curve. 
𝐼𝑠𝑜𝑠𝑏𝑒𝑠𝑡𝑖𝑐 𝑃𝑜𝑖𝑛𝑡 𝑅𝑒𝑙𝑎𝑡𝑖𝑜𝑛 (𝐼𝑃𝑅) =
𝑆𝐻𝐵 𝑎𝑟𝑒𝑎
𝑊𝐻𝐵 𝑎𝑟𝑒𝑎
       (3.6) 
2. The five peaks method: To evaluate the spectrum it is helpful to describe the 
spectrum as the sum of five Gaussian peaks. As it is shown in the following 
figure, the first and second peaks correspond to SHB section; and the last 
three peaks describe WHB section. 
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Figure 3.15 Decomposition spectrum into five Gauss peaks 
By the creation of a new variable, a new relation between both sections can be built. 
𝑅 =
𝑆𝐻𝐵
𝑊𝐻𝐵
=
𝑃𝑒𝑎𝑘 1 + 𝑃𝑒𝑎𝑘 2
𝑃𝑒𝑎𝑘 3 + 𝑃𝑒𝑎𝑘 4 + 𝑃𝑒𝑎𝑘 5
       (3.7) 
In table 3.2 resumes the characteristics of the peaks: central wavelength and 
standard deviation. 
N° of peak Central wavelength Standard deviation 
1 3051 100 
2 3225 88 
3 3400 89 
4 3500 96 
5 3628 43 
Table 3.2 Characteristics of the peaks: Central wavelength and standard deviation 
4. Experimental 
On this section, the writer will focus the attention on inhibitors and equipment 
description. Moreover, along the last sub-sections, the theoretical explanation and 
the procedure for the experiments are also described. 
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4.1. Chemicals 
The chemicals used along the duration of this bachelor project were: 
 Deionized water 
 CO2 (guest molecule) 
Moreover, the inhibitors were: 
a) HI-M-PACT HIW 85671 (Ethandiol and 2-butoxyethanol) 
b) HI-M-PACT HIW 85610 (2-butoxyethanol) 
c) HI-M-PACT 85232 HCW (2-butoxyethanol, ethandiol and quaternary 
ammonium compounds) 
d) Luvicap BIO (PVCap copolymer in BGE) 
e) Luvicap 55W (VP:VCap copolymer) 
f) Luvicap PL (2H-Azepin-2-one, 1-ethenylhexahydro-homopolymer in ethanol) 
g) Luvicap EG (low molecular weight PVCap in MEG) 
h) Luvicap EG-HM (low molecular weight PVCap in MEG and quaternary 
ammonium compounds). 
i) PVP (Polyvinylpyrrolidone) 
j) TBAB (Tetrabutylammoniumbromide) 
k) Starch, from potato 
Where PVCap means polyvinylcaprolactam, MEG means monoethylene glycol, VP 
means vinylpirrolidone, and BGE means mono butyl glycol ether. 
The relevant components and concentration of the chemicals are shown in table 4.1. 
Chemical Concentration (Component) 
TBAB 50 wt. % solution in water 
Luvicap EG 40 wt. % in MEG 
Luvicap EG-HM 40 wt. % in MEG 
Luvicap BIO 40 wt. % in BGE 
HI-M-PACT HIW 85610 50-75 wt. % in water 
HI-M-PACT HIW 85671 
35-50 wt. % in water (ethandiol) 
10-20 wt. % in water(2-butoxyethanol) 
HI-M-PACT 85232 HCW 
35-50 wt. % in water (ethandiol) 
10-20 wt. % in water(2-butoxyethanol) 
Table 4.1.Concentrations of the gas hydrate inhibitors 
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More detail information about security and some properties of each product are 
attached in Appendix B. Safety Sheets. 
For this experiments is assume that all the guest molecule works in the same way, 
that is why CO2 was chosen as a guest molecule and also because it specific 
properties such as low size, stable at high pressure and because it is safer than 
methane and propane which are flammable gases. 
 
Figure 4.1 Inhibitor samples: HI-M-PACT HIW 85671 (a), HI-M-PACT HIW 85610 (b),HI-M-PACT 85232 HCW (c), 
Luvicap Bio (d),Luvicap 55 W (e),Luvicap PL (f),Luvicap EG (g), Luvicap EG HM (h),PVP (i),TBAB (j),Starch (k) 
Figure 4.1 shows the inhibitors appearances. From (a) to (h) the inhibitors are liquids 
while the last three (PVP, TBAB and starch) are solids at normal conditions. From (a) 
to (e) the inhibitor’s viscosity is comparable to the water while for Luvicap PL, EG and 
EG HM (f, g and h), the viscosity was higher and similar to honey. Another 
remarkable property of Luvicap Bio inhibitor (d) is that is almost opaque, and HI-M-
PACT HIW 85610, Luvicap Bio, Luvicap 55 W, Luvicap EG and Luvicap EG HM (b, d, 
e, g and h) are yellow and brown colored. Finally, PVP and starch are powder while 
TBAB have a crystal structure. 
For the optimal preparation of the mixtures, the writer gathers the information about 
the best proportion on the following references [11, 52-55]. The samples have the 
following composition as shown in table 4.2. 
Sample Inhibitor´s name Inhibitor weight percent (wt.inhibitor%) 
a) HI-M-PACT HIW 85671 1.064 wt. % 
b) HI-M-PACT HIW 85610 0.9695 wt % 
c) HI-M-PACT 85232 HCW 1.026 wt % 
d) Luvicap Bio 0.654 wt % 
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e) Luvicap 55 W 0.648 wt % 
f) Luvicap PL 0.6017 wt % 
g) Luvicap EG 0.558wt % 
h) Luvicap EG HM 0.55 wt % 
i) PVP 0.0717 wt. % 
j) TBAB 0.4681 wt. % 
k) Starch 0.0684 wt. % 
Table 4.2 Inhibitor weight percent of the samples using in this project 
4.2. Experimental setup 
In these experiments, inhibitor performance tests are carried out in a Raman 
scattering instrumentation. Figure 4.2 shows the entire equipment. The central part is 
the cell (C), which is connected to two pumps (Teledyne Isco syringe pumps model 
260-D); one provides CO2 (A) and the other provides water (B). There is also one 
more connection in case of 
inject manually the sample into 
the cell. The high-pressure 
variable volume view cell has 
four optical accesses and a 
piston to modify the volume (D). 
In order to control the 
temperature, the cell has a 
double walled jacket in which a 
refrigerant can circulate though. 
A cryo compact thermostat 
CF41 by Julabo (F12-ED from 
Julabo) accomplishes the 
temperature regulation of the 
cell (E) and the temperature 
inside the cell was continuously 
measured with a Pt100 
thermometer and recorded (F). 
In order to control the pressure, 
Figure 4.2 Laboratory instrumentation 
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the cell has two sensors inside and for security reasons, one connection for pressure 
release in case of the pressure exceed the safety limit. 
The cell has a connection to remove the gas, which guide the gas to the residual 
ventilation system. A screwed button located at bottom empties the cell from the 
liquids. 
The cell has four windows, which are located 90° from one another. One of them is 
used for the optical setup. Because of the difference of temperature during the 
experiment, on this window was added a compressed air device to prevent water 
condense on the glass. The opposite one is blocked so the light cannot pass to the 
other side. A camera located on the third window monitors the inside and finally, the 
fourth window is free of devices. 
Furthermore, inside of the cell, a magnetic agitator positioned at the bottom of the cell 
continuously agitates the liquid water-rich phase and thus assures a good mass 
transport between the liquid water-rich phase at the bottom of the cell and the liquid 
CO2 rich phase at the top. 
Finally, and in order to determine the influence of the external factors, the 
temperature of the room was measured by two sensors controlled by OMEGA TC-08. 
The first sensor (G) was at the same height of the table and the other one a little bit 
higher (H). 
For the measurement, Raman sensor provides the Raman spectra from the liquid 
water rich phase in a backscattering arrangement. Individual Raman spectra are 
recorded in direct sequence. [52]. Figure 4.3 is a brief scheme of how the Raman 
scattering instrumentation works. 
 
Figure 4.3 Experimental setup consisting of the high-pressure cell and the optical setup [20] 
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For excitation a frequency-doubled Nd: YAG laser type 532-250-AC from CNI with a 
wavelength of 532 nm and a power output of 250 mW was used. The beam is 
widened and collimated by a concave and a convex lens (L1 and L2). After that, the 
beam hits a dichroitic mirror (DCM) that reflects light with wavelengths shorter than 
532 nm(𝜆𝑟𝑒𝑓𝑙𝑒𝑐𝑡𝑒𝑑 < 532 𝑛𝑚) and transmits light with wavelengths longer than 544 
nm(𝜆𝑡𝑟𝑎𝑛𝑠𝑚𝑖𝑡𝑡𝑒𝑑 > 532 𝑛𝑚). Therefore, the excitation radiation is reflected and guided 
through a convex lens (L 3) that focuses the laser beam into the sample cell. Inside 
the cell, the incident light is scattered elastically and inelastically. The inelastically 
scattered Raman signals are detected in backscattering direction. The scattered light 
is collimated by the convex lens L3 and transmitted by the dichroitic mirror. 
Additionally, to the dichroitic mirror a long-pass filter (LPF) is placed in the optical 
path to remove the remaining elastically scattered light that was transmitted through 
the dichroitic mirror. Subsequently, the signals are launched into an optical fiber and 
guided to the spectrometer QE65Pro from Ocean Optics. Finally, a complete Raman 
spectrum, which it is unique for every single element, is obtained [20]. 
4.3. Procedure 
a. Initial experiments at normal pressure 
The first experiments (pure samples) were in a cuvette instead of the cell. Pure water 
and the inhibitors by their own were measured to produce the pure spectra. These 
experiments were done at atmospheric pressure and 22°C. The software that was 
used to display the spectra was OceanView. With this software, it is possible to 
configure the graph and avoid the noise of unwanted elements just recording the 
background before starting the measurements.  
After that, the optimal solutions between the inhibitor and the water were prepared 
and compared [11, 53-57]. The same procedure at it was explained before was 
followed and the text files were processed with Matlab. 
b. Experiments at 6 MPa 
The experiments at high pressure take place 1n the cell explained in section 4.2. 
First, the cell was cleaned and flushed with water two times, and the refrigerant was 
set to 13 °C. For introducing the mixtures, the manual connection was used with the 
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help of a syringe. The cell was not completely full in order to watch the surface 
through the windows. Then all the connections were closed except the CO2 pump 
connection and the cell pressurized with CO2 to 6 MPa. Mixing time usually takes 
approximately two hours until the equilibrium CO2-water is completed. 
After this step, the temperature decreases constantly (3°C per hour) to form the 
hydrates. Generally, hydrates formation at these conditions occurs at temperature 
below 10°C so set point temperature is configured at 1°C. To analyze the kinetic of 
the inhibitors, the mixture stays between 3 to 5 hours at 1°C. Once the hydrate 
formation starts, a hydrate film is formed at the meniscus between the two liquid 
phases and the formation spreads and develops through the sample (figure 4.4). 
During the cooling and isothermal period, the fluids inside the cell were monitored 
with a camera and the corresponding snapshots, which are shown in figure 4.4, were 
continuously recorded with a frequency of 15 fps and labeled with a time stamp. 
 
Figure 4.4 Photographs of the substances inside the cell during hydrate formation: transparent water-rich 
phase before hydrate formation (a), start of hydrate formation at the interface between CO2-rich and water-
rich phase (b), and further hydrate formation in the water-rich phase and development of a slurry of solid 
hydrate dispersed in liquid water (c, d). 
To complete the measurement, the temperature was increased continuously to 13°C 
and suddenly to 25°C to dissociate completely the hydrate and start again the 
process. 
Furthermore, the temperature and pressure inside the cell, the laboratory´s 
temperature and the refrigerant´s temperature were measured and recorded, and the 
Raman spectra, with an integration time of one second each, were recorded in 
different files. 
In total, each sample repeats the cycle three times. Then the cell was depressurized 
and the sample was removed, in order to begin the next measurement. 
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c. Data Evaluation 
The software OceanView give the possibility of choosing the number of scan 
averaged (10) and the integration time (1s). The data obtained from this software are 
run in Matlab. From the running of the code, the raw data are modifying. Firstly, it is 
obtain the spline correction in order to remove the fluorescence of the diagram. The 
spline correction function identifies and removes the intensity of the points inside the 
range of Raman shift where the intensity is supposed to be null.  
Secondly, from the data resulting from the spline correction, the spectrum is 
normalized to the maximum. This is done in order to dismiss the different sensibility 
that the spectroscope has depending on the sample. Finally, the normalized 
spectrum is decomposed into five Gaussian peaks to quantify the R-value, which has 
been explained in section 3.3.3. 
5. Results and Discussion 
5.1. Raman Spectra of pure inhibitors and solutions 
The first type of experiments (pure inhibitors) were measured in a cuvette at 22 °C 
(room temperature) and 1 atm. The spectrum provides the results, as shown in figure 
5.1. 
Most of the spectra cannot be shown because the spectrometer was saturated. For 
that reason, it was impossible to back up the conclusion from them. 
The other three diagrams can be evaluated. Luvicap Bio has more fluorescence 
because of 2-butoxyethanol. This is also proven by the saturated spectra of the three 
HI-M-PACT inhibitors. For the three of them there is the same component, 2-
butoxyethanol, and the only differences between them are the solvents and that HI-
M-PACT 85232 HCW has a low concentration of quaternary ammonium compounds. 
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Figure 5.1 Raw Raman spectra from kinetic hydrate inhibitors tested with a green laser: Luvicap BIO (d), Luvicap 
55W (e) and Luvicap PL (f) 
Some similarities between Luvicap PL, Luvicap 55W and their solvents can be 
observe in figure 5.1. Luvicap PL (f) is dissolved in ethanol while Luvicap 55W and 
BIO (d and e) have water; it is easy to distinguish the O-H stretching from water and 
ethanol on the spectra between 3200 and 3500 cm-1. In addition, the main peak is 
related to the C-H stretching due to the polymeric chains. 
The pure inhibitors were tested with an infrared (IR) laser, because of the lack of 
results with the green laser. The spectra obtained are shown in figure 5.2: 
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Figure 5.2 Normalized Raman spectra from kinetic hydrate inhibitors tested with an IR laser: HI-M-PACT HIW 
85671 (a), HI-M-PACT HIW 85610 (b), HI-M-PACT 85232 HCW (c), Luvicap Bio (d), Luvicap 55 W (e), Luvicap 
PL (f), Luvicap EG (g), Luvicap EG HM (h), PVP (i), TBAB (j), Starch (k) 
The inhibitor spectra show that along the range where the water stretching is located, 
the signal in most of the inhibitors is low. This means that the inhibitors would not 
influence the following measurements with the mixtures inhibitor-water and 
consequently, the measurements can be completed without problems. However, 
some of them have a weak O-H stretching signal so they were tested the solutions 
verify the influence on the spectrum. 
Then, the mixtures of inhibitor and water were prepared and measured in a cuvette at 
the same conditions as the pure inhibitors (T= 22 °C; p=1 atm). Figure 5.3 and 5.4 
show the comparison of the multiple normalized spectra and some detail for a better 
view. 
 
Figure 5.3 Normalized spectra comparison of the mixture between Luvicap inhibitors with water, 1) shows a 
magnification between the Raman Shift 2600 and 3100 cm
-1
 and 2) shows a magnification between the Raman 
Shift 3230 and 3340 (Isosbestic Point) 
1) 2) 
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Figure 5.4 Normalized spectra comparison of the mixture between solids or HI-M-PACT inhibitors with water, 1) 
shows a magnification between the Raman Shift 2600 and 3100 cm
-1
 and 2) shows a magnification between the 
Raman Shift 3230 and 3340 (Isosbestic Point) 
From these figures, the result that can be obtained is that there are no visual 
differences between the spectra of the pure water and the one of the mixtures. This is 
because the kinetic inhibitors have no influence on the hydrogen bonds. This can be 
demonstrated with the comparison of the R-value and the isosbestic point relation 
(IPR) as in figure 5.5 and 5.6. The R and the IPR-values of the pure water only defer 
a few hundredths from the mixture values. 
 
Figure 5.5 R comparisons between deionized water and samples with water and kinetics inhibitors 
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Figure 5.6 IPR comparisons between deionized water and samples with water and kinetics inhibitors 
5.2. Experiments at 6 MPa 
The second type of experiments was performed at high pressure (6 MPa). The 
samples that were used and their properties are shown in table 5.1. 
N° measurement Components Inhibitor weight percent 
1 Water 0 wt. % 
2 Water + Luvicap PL 0.6 wt. % 
3 Water + Luvicap 55W 0.65 wt. % 
4 Water + Luvicap PL 1 wt. % 
5 Water + HI-M-PACT 85232 HCW 1.03 wt. % 
Table 5.1 Properties of the samples that were measured at high pressure 
Each measurement consists of three cycles or repetitions that will be classified with 
an A, B or C. 
In these experiments, the temperature inside the cell, the R and IRP-value, CO2 
concentration in water and the maximal intensity of the spectrum were measured 
along the time. To short the section, the representation of IRP-value is not going to 
be represented because it has the same tendency as the R-value. 
Firstly and for a better explanation, the writer is going to describe the changes of 
these parameters when the sample is deionized water. Secondly, the writer is going 
to describe the samples water-inhibitors and to compare them with the water sample. 
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To see all the results and graphs of the different measurements, see Appendix C. 
Measurements. 
a. Water + CO2 
The graphs correspond with one cycle of the measurement and can be divided into 
three sections: constant cooling (indicated with the number 1), isothermal period 
(indicated with the number 2) and constant heating (indicated with the number 3). 
In figure 5.7 (a) and (b) are plotted some of the parameters that give some 
explanation about what happen to a sample with water and CO2. Figure 5.7 (a) 
displays the maximum intensity and the temperature over the experimental time while 
figure 5.7 (b) displays the R-value and the CO2 concentration in water over the 
temperature. 
 
Figure 5.7 Behavior of the measured parameters when the sample is deionized water and CO2. (Measurement 
1B). Temperature inside the cell and the maximal intensity of the spectrum versus the time (a) CO2 concentration 
in water and R-value versus temperature inside the cell (b) 
It is remarkable that in figure 5.7 (a) when the temperature is approximately 1ºC, the 
temperature instantaneously increases, between one or two degrees, and the 
maximal intensity drops until a minimum value (point 2). This is typical when the gas 
hydrate formation takes place. 
Focusing now on figure 5.7 (b), it is possible to describe the effects of the gas 
hydrate formation on the R-value and the CO2 concentration in water. During the 
cooling, the R-value increases linearly. When the temperature is near 1ºC, the R-
value suffers an increment due to the gas hydrate formation. Finally, along the 
heating period, the R-value decreases and during the gas hydrate dissociation, the 
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R-value drops until a minimum value (R=0.65) and finally, it reaches the original 
value. 
The concentration of CO2 in water increases linearly during the cooling. When the 
gas hydrate instantaneously forms, the CO2 concentration in water increases, but has 
not a single value instead, it is a diffusive range. Finally, along the third period 
(constant heating), the gas hydrate dissociates and the cycle starts again. 
 
Figure 5.8 Detail of gas hydrate formation when the sample is water and CO2 (Measurement 1A).Picture of the 
cell when the gas hydrate has not formed (a) Pictures of the cell while the gas hydrate formation takes place (b-e) 
Figure 5.8 shows how the gas hydrate formation takes place and give some 
information about the characteristic of the gas hydrates formation reaction: 
1) The reaction is fast. It takes place in a few seconds. 
2) The reaction appears during the first or second period. 
3) The reaction begins at the surface of the water-rich phase. 
4) R-value increases. 
5) The reaction is exothermic. 
6) Maximal intensity decreases. 
7) During the formation, the CO2 is trapped by the hydrate structure and 
consequently, the concentration increases. 
b. Water + Inhibitor + CO2  
During the following measurements, the gas hydrate formation did not appear: 
 Water+ Luvicap PL(0.6 wt. %) + CO2 (Measurement 2 A) 
 Water + Luvicap 55 W (0.65 wt. %) + CO2 (Measurement 3 A, B and C) 
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 Water + HI-M-PACT 85232 HCW (1.03 wt. %) + CO2 (Measurement 5 A, B 
and C) 
Comparing with the graphs of the mixture water-CO2, the R-value and the 
temperature suffer remarkable changes as it is shown in figure 5.9. The first 
difference is that the peak related to the increment of temperature does not appear. 
This means that during the cooling and isothermal period, the gas hydrate does not 
form and consequently, the R-value follows a linear tendency (remember that in 
figure 5.7, the R-value increases during point 2 and 3). 
 
Figure 5.9 Behavior of the measured parameters when the sample is deionized water, Luvicap 55 W and CO2. 
(Measurement 3 B). Temperature inside the cell and the maximal intensity of the spectrum versus the time (a) 
CO2 concentration in water and R-value versus temperature inside the cell (b) 
Then, when the temperature starts to increase and reaches 2°C, the maximal 
intensity decreases and a reaction, which will be called the “kinetic-hydrate reaction” 
and is shown in detail in figure 5.10, begins. The characteristics of this reaction are: 
1) The reaction is slow. It takes some minutes to complete. 
2) The reaction appears at the third period. 
3) The reaction can begin at any point of the rich-water phase. 
4) R-value decreases. 
5) No temperature rise can be observed. Perhaps, the reaction is exothermic but 
the increment of temperature goes slowly and little by little and that is why it 
cannot be measured. 
6) Maximal intensity decreases. 
7) During the formation, the CO2 is trapped by the hydrate structure and 
consequently, the concentration increases. 
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Figure 5.10 Detail of gas hydrate formation when the sample is water, Luvicap 55 W and CO2 (Measurement 
3 B) Picture of the cell when the gas hydrate has not formed (a). Pictures of the cell while the kinetic-hydrate 
reaction takes place (b-d) 
As it is observed in the pictures from (b) to (d) in figure 5.10 and the above-
mentioned characteristics, the reactions have many differences (from 1 to 4) and 
some similarities (6 and 7).  
The behavior for the R-value during the cooling and isothermal period is predictable 
because the gas hydrate does not form and consequently, the R-value increases 
while the temperature decreases and stays at the same point when the temperature 
is constant. While the gas hydrate formation is spreading, the R-value decreases until 
a minimum (approximately 7ºC), then the dissociation begins and the R-value 
increases.  
The CO2 concentrations in water suffer the opposite behavior. The concentration of 
CO2 in water increases linearly during the cooling. When the gas hydrate 
instantaneously forms, the CO2 concentration in water increases, but has not a single 
value instead, it is a diffusive range. Finally, along the third period (constant heating), 
the gas hydrate dissociates and the cycle starts again. The only difference with the 
mixture water-CO2 is that the maximum concentration is at a lower temperature, so 
the gas hydrate dissociation starts earlier. 
The writer suggest one explanation for the behavior of the mixture and the kinetic-
hydrate reaction. The polymeric chains, and particularly the active groups (amines), 
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interfere with the nucleus during the cooling and isothermal periods, but when the 
temperature increases, the hydrate growth begins, which is also indicated because 
the CO2 concentration in water increases, but due to the kinetic inhibitor, the reaction 
is slower and because of that, the increment of temperature cannot be observed. The 
interaction between the polymeric chains and the nuclei is strong and deactivate the 
hydrate molecules. This explains why the R-value drops. When these interactions 
disappear when the dissociation begins, the R-value increases to the original values. 
In the case of HI-M-PACT 85232 HCW, the graphs in figure 5.11 show that is less 
effective than the other measured inhibitor. Largely because the R-value is increasing 
and decreasing linearly and does not suffer high variation and the CO2 concentration 
is higher (0.08) (remember that in figure 5.9 the maximum was at 0.045). This 
means, that the interaction are not as strong as the other inhibitor. 
 
Figure 5.11 Behavior of the measured parameters when the sample is deionized water, HI-M-PACT 85232 HCW 
and CO2. (Measurement 5 C). Temperature inside the cell and the maximal intensity of the spectrum versus the 
time (a) CO2 concentration in water and R-value versus temperature inside the cell (b) 
Nevertheless, the inhibitors are not always effective. This appears when the sample 
contains an inhibitor but it does not work and the gas hydrate forms. This case 
happened in the following measurements: 
 Water+ Luvicap PL(0.6 wt. %) + CO2 (Measurement 2 A) 
 Water + Luvicap PL (1 wt. %) + CO2 (Measurement 4 A, B and C) 
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Figure 5.12 Behavior of the measured parameters when the sample is deionized water, Luvicap PL and CO2. 
(Measurement 4 A). Temperature inside the cell and the maximal intensity of the spectrum versus the time (a) 
CO2 concentration in water and R-value versus temperature inside the cell (b) 
Figure 5.12 (a) and (b) show the formation of the gas hydrate at approximately 4 ºC. 
The properties seem to be the same as the water-CO2 case (the temperature and de 
CO2 concentration in water increase while the maximal intensity decreases) but the 
R-value decreases instead of reaching a higher value. After that, the R-value is still 
decreasing and during the isothermal period, it continuously increasing until the 
maximum point (R=0.81). This maximum point is a little bit lower than the mixture 
water-CO2. Finally, during the heating period, the gas hydrate dissociates. 
 
Figure 5.13 CO2 concentrations in water and R-value versus temperature inside the cell (Measurement 4 B). 
Picture of the cell during the cooling period when the temperature is 8.12 ºC (a) Picture of the cell during the 
cooling period when the temperature is 3.65 ºC (b) Picture of the cell during the cooling period when the 
temperature is 2.57 ºC (c) 
It is also remarkable that during the cooling period, the R-value suffers some fallings 
and increments. Figure 5.13 reveals that during the increments of R-value the light 
beam is not focus, but during the decrements, the laser beam is focalized in the 
sample. 
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Figure 5.14 Behavior of the measured parameters when the sample is deionized water, Luvicap PL and 
CO2.(Measurement 4 C) Temperature inside the cell and the maximal intensity of the spectrum versus the time (a) 
CO2 concentration in water and R-value versus temperature inside the cell (b) 
During the third cycle of measurement 5, another significant event takes places as is 
shown in figure 5.14. Along the isothermal section, the R-value increases 
instantaneously from the minimum point (R=0.55) to the maximum (R=0.8). 
6. Conclusion 
In this work, a variety of KHIs had been tested for gas hydrate inhibition using Raman 
spectroscopy. The following conclusions can be drawn from the results that have 
been obtained. 
From the first type of experiments at atmospheric pressure can conclude that KHIs 
do not shift the equilibrium to WHB and SHB water molecules at normal conditions. 
As it is known, just thermodynamic inhibitors shift the equilibrium. 
Secondly, and focusing on the second type of experiments, more conclusions can be 
drawn. When KHIs inhibit the hydrate formation, they have an influence on the R-
value because of the interferences of the polymeric chains in the gas hydrate 
structure. 
The concentration of KHI has an influence, as it was shown during the 
measurements of Luvicap PL at the optimal concentration (0.6 wt. %) and the 
maximum concentration for KHI (1 wt. %). When the inhibitors are not at the optimal 
concentration, it does not inhibit the gas hydrate formation as it happens with Luvicap 
PL at 1 wt. %. 
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Although, Luvicap PL shows some problems during measurement 3 A because did 
not inhibit gas hydrate formation at the optimal concentration. Just in measurement 3 
C, the inhibitor works properly. For this reason, it could be possible that the sample 
was not in good conditions and perhaps the inhibitor was degraded during the 
storage time or during the experiment. 
When the KHIs works properly, then the kinetic-hydrate reaction always takes place 
when the temperature is starting to rise, that means, that the temperature is between 
1ºC and 2ºC. In addition, Luvicap 55 W and HI-M-PACT 85232 HCW follow the same 
pattern in spite of the difference of the components; this means that all the KHI works 
in a similar way. Nevertheless, Luvicap 55 W is more effective and ensures the 
mixture to stay stable because the interaction with the nuclei are stronger than with 
the others. 
Finally and because this topic need to be investigated in more detail. More 
measurements should be done for a better determination of the influence of KHIs. It 
is also important to make some researches on how KHIs work and how can change 
the kinetic of the reaction. Carrying out a study about the gas hydrate formation does 
not start at the surface of the water rich phase can be also interesting and can give 
some clues about kinetics inhibitors. 
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Appendix B. Safety Sheets 
HI-M-PACT HIW 85671 
Name: HI-M- PACT HIW85671 
Firma: Baker Hughes 
Components 
1. Ethandiol (35-50wt. %) 
2. 2-butoxyethanol (10-20wt. %) 
Rate: It can be applied at 0.1-1 wt. % based on water production. 
Safety (HA: Help Aids) 
Main Hazards: Harmful. Danger of serious damage to health by prolonged 
exposure if swallowed 
 
Hazardous ingredients: Ethandiol 
R-phases: 
 R20/21/22: Harmful by inhalation and in contact with skin 
 R36/38: Irritating to eyes and skin 
 R48/22: Harmful: danger of serious damage to health by prolonged 
exposure through inhalation. 
S-phases:  
 S26: In case of contact with eyes, rinse immediately with plenty of water 
and seek medical advice. 
 S36: Wear suitable protective clothing. 
Prevention: 
 Wear protective gloves. Wear eye or face protection. Do not breathe 
vapor. 
Response: 
 Get medical attention if you feel unwell. If swallowed: call a poison 
center or physician if you feel unwell. 
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HI-M-PACT HIW 85610 
 
Name: HI-M- PACT HIW85610 
Firma: Baker Hughes 
Components 
1. 2-butoxyethanol (50-75wt. %) 
Rate: It can be applied at 0.1-1 wt. % based on water production. 
Safety (HA: Help Aids) 
Main Hazards: Harmful. Danger of serious damage to health by prolonged 
exposure if swallowed 
 
Hazardous ingredients: 2-butoxyethanol 
R-phases: 
 R20/21/22: Harmful by inhalation and in contact with skin 
 R36/38: Irritating to eyes and skin 
 R48/22: Harmful: danger of serious damage to health by prolonged 
exposure through inhalation. 
S-phases:  
 S26: In case of contact with eyes, rinse immediately with plenty of water 
and seek medical advice. 
 S36: Wear suitable protective clothing. 
Prevention: 
 Wear protective gloves. Wear eye or face protection. Do not breathe 
vapor. 
Response: 
 Get medical attention if you feel unwell. If swallowed: call a poison 
center or physician if you feel unwell. 
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HI-M-PACT 85232 HCW 
Name: HI-M- PACT 85232 HCW 
Firma: Baker Hughes 
Components 
1. Ethandiol (20-25 wt. %) 
2. 2-butoxyethanol (10-20 wt. %) 
3. Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides 
(0.1-15 wt. %) 
Rate: It can be applied at 0.1-1 wt. % based on water production. 
Safety (HA: Help Aids) 
Main Hazards: Harmful. Danger of serious damage to health by prolonged 
exposure if swallowed 
Hazardous ingredients: Ethanediol 
R-phases: 
 R20/21/22: Harmful by inhalation and in contact with skin 
 R34: Causes burns 
 R36/38: Irritating to eyes and skin 
 R48/22: Harmful: danger of serious damage to health by prolonged 
exposure through inhalation. 
 R50: Vey toxic to aquatic organisms 
S-phases:  
 S26: In case of contact with eyes, rinse immediately with plenty of water 
and seek medical advice. 
 S36: Wear suitable protective clothing. 
Prevention: 
 Wear protective gloves. Wear eye or face protection. Do not breathe 
vapor. 
Response: 
 Get medical attention if you feel unwell. If swallowed: call a poison 
center or physician if you feel unwell.  
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Luvicap BIO 
 
Name: Luvicap BIO 
Firma:BASF SE 
Components 
1. Vinylcaprolactam (VCap) 
2. Water (dissolvent) 
3. Mono butyl glycol ether. 
Rate: It can be applied at 0.5 wt. % to 3 wt. % based on water production. 
Safety (HA: Help Aids) 
Main Hazards: Harmful. Danger of serious damage to health by prolonged 
exposure if swallowed 
 
Hazardous ingredients: Ethandiol 
R-phases: 
 R22: Harmful if swallowed 
 R48/22: Harmful: danger of serious damage to health by prolonged 
exposure through inhalation. 
  
S-phases:  
 S2: Keep out of the reach of children 
 S45: In case of accident or if you feel unwell seek medical advice 
immediately (sow the label where possible) 
Prevention: 
 Do not breathe vapor. 
Response: 
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Luvicap 55W 
 
Name: Luvicap 55W 
Firma: BASF SE 
Components 
1. 1-Vinyl-2-pyrrolidone. 
2. 1-vinylhexahydro-2H-azepin-2-one 
3. Water (dissolvent) 
Rate: Approximately 0.4 wt. % or 4000 ppm. 
Safety (HA: Help Aids) 
Main Hazards: No particular hazards known if the standards are met / notes 
for storage and handling. 
 
Hazardous ingredients: 
R-phases: 
  
S-phases:  
Prevention: 
Response: 
 Immediately and rinse for at least 15 minutes holding the eyelids apart 
thoroughly under running water, ophthalmologist. 
 Rinse mouth and drink plenty of water. 
 Wash thoroughly with soap and water.  
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Luvicap PL 
 
Name: Luvicap PL 
Firma: BASF SE 
Components 
1. 2H-Azepin-2-one 
2. 1-ethenylhexahydro-homopolymer 
3. Ethanol (dissolvent) 
Rate: It can be applied at 0.5 vol% to 0.75 vol% based on water production. 
Safety (HA: Help Aids) 
Main Hazards: Harmful. Danger of serious damage to health by prolonged 
exposure if swallowed 
Hazardous ingredients: Ethanol  
R-phases: 
 R11: Highly flammable. 
 R38: Irritating to skin. 
 R41: Risk of serious damage to eyes. 
S-phases:  
 S7: Keep container tightly closed 
 S16: Keep away from sources of ignition- No smoking 
 S24/25: Avoid contact with skin and eyes 
 S26: In case of contact with eyes, rinse immediately with plenty of water 
and seek medical advice. 
 S28.1: After contact with skin, wash immediately with soap and water 
 S37/39: Wear suitable gloves and eye/face protection. 
Prevention: 
 Wear protective gloves. Wear eye or face protection.  
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Luvicap EG 
Name: Luvicap EG 
Firma: BASF SE 
Components 
1. Polyvinylcaprolactam 
2. Ethandiol (Glycol) (50-75wt. %) (dissolvent) 
Rate: It can be applied at 0.5 vol. % to 3 vol. % based on water production. 
Safety (HA: Help Aids) 
Main Hazards: Harmful. Danger of serious damage to health by prolonged 
exposure if swallowed 
 
Hazardous ingredients: Ethan-1,2-diol  
 
R-phases: 
 R22: Harmful if swallowed 
 R48/22: Harmful: danger of serious damage to health by prolonged 
exposure through inhalation. 
  
S-phases:  
 S2: Keep out of the reach of children 
 S36/37: Wear suitable protective clothing and gloves 
 S45: In case of accident or if you feel unwell seek medical advice 
immediately (sow the label where possible) 
Prevention: 
 Wear protective gloves. Wear eye or face protection. Do not breathe 
vapor. 
Response: 
 Get medical attention if you feel unwell. If swallowed: call a poison 
center or physician if you feel unwell. 
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Luvicap EG-HM 
Name: Luvicap EG-HM 
Firma: BASF SE 
Components 
1. Polyvinylcaprolactam 
2. Ethandiol (Glycol) (50-75wt. %) (dissolvent) 
3. Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides 
(0.1-15wt. %) 
Rate: It is used just in low proportion (0.5 wt. %). 
Safety (HA: Help Aids) 
Main Hazards: Harmful. Danger of serious damage to health by prolonged 
exposure if swallowed 
 
Hazardous ingredients: Ethan-1,2-diol 
R-phases: 
 R22: Harmful if swallowed 
 R48/22: Harmful: danger of serious damage to health by prolonged 
exposure through inhalation. 
  
S-phases:  
 S2: Keep out of the reach of children 
 S36/37: Wear suitable protective clothing and gloves 
 S45: In case of accident or if you feel unwell seek medical advice 
immediately (sow the label where possible) 
Prevention: 
 Wear protective gloves. Wear eye or face protection. Do not breathe 
vapor. 
Response: 
 Get medical attention if you feel unwell. If swallowed: call a poison 
center or physician if you feel unwell.  
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PVP 
Name: Polyvinylpyrrolidone. 
Firma: Merck Millipore 
Components 
1. Polyvinylpyrrolidone 
Rate: It is used just in low proportion (0-0.07 wt. %). 
Safety (HA: Help Aids): 
Hazardous ingredients: Polyvinylpyrrolidone 
Prevention: 
 Wear protective gloves. Wear eye or face protection.  
Response: 
 Eye contact: Immediately flush eyes with plenty of water for at least 15 
minutes, occasionally lifting the upper and lower eyelids. Check for and 
remove any contact lenses. Get medical attention if irritation occurs. 
 Skin contact: Flush contaminated skin with plenty of water. Remove 
contaminated clothing and shoes. Get medical attention if symptoms 
occur. Wash clothing before reuse. 
 Inhalation: Move exposed person to fresh air. Keep person warm and at 
rest. If not breathing, if breathing is irregular or if respiratory arrest 
occurs, provide artificial respiration or oxygen by trained personnel. It 
may be dangerous to the person providing aid to give mouthto-mouth 
resuscitation. Get medical attention if symptoms occur. 
 Ingestion: Wash out mouth with water. If material has been swallowed 
and the exposed person is conscious, give small quantities of water to 
drink. Stop if the exposed person feels sick as vomiting may be 
dangerous. If vomiting occurs, the head should be kept low so that 
vomit does not enter the lungs. Get medical attention if symptoms 
occur.  
 Protection of first-aiders: No action shall be taken involving any 
personal risk or without suitable training  
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TBAB 
Name: Tetrabutylammoniumbromide. 
Firma: Merck 
Components 
1. Tetrabutylammoniumbromide (50% solution in water). 
Rate: It is used just in low proportion (1 wt. %) or between 1000-5000 ppm. 
Safety (HA: Help Aids): 
Main Hazards: Harmful 
 
Hazardous ingredients: Tetrabutylammoniumbromide 
 
R-phases: 
 R20: Harmful by inhalation 
 R22: Harmful if swallowed 
 R36: Irritating to eyes 
 R37: Irritating to respiratory system 
 R38: Irritating to skin 
  
S-phases:  
 S26: In case of contact with eyes, rinse immediately with plenty of water 
and seek medical advice. 
 S36: Wear suitable protective clothing. 
Prevention: 
 Wear protective gloves. Wear eye or face protection. Do not breathe 
vapor. 
Response: 
 Get medical attention if you feel unwell. If swallowed: call a poison 
center or physician if you feel unwell. 
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Starch, from potato 
 
Name: Starch, from potato, soluble 
Firma: Alfa Aesar GmbH & Co. KG 
Components 
1. Amylase 
2. Amylopectin 
Rate: It can be applied at 0.5 wt. % 
Safety (HA: Help Aids) 
Main Hazards:  
 
Hazardous ingredients: 
 
R-phases: 
 
S-phases:  
Prevention: 
 Wear protective gloves. Wear eye or face protection. Do not breathe 
vapor. 
Response: 
 Breathe in: Fresh air, if necessary give artificial respiration heat. Then 
consult a doctor. 
 Contact with the skin: wash with water and soap. 
 Contact with the eyes: Immediately and rinse for at least 15 minutes 
holding the eyelids apart thoroughly under running water, 
ophthalmologist. 
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Appendix C. Measurements 
Measurement 1 
 
 
Figure C.1 Measurement 1 A(water and CO2): Temperature inside the cell and the 
maximal intensity of the spectrum versus the time  
 
Figure C.2 Measurement 1 A (water and CO2):CO2 concentration in water and R-
value versus temperature inside the cell 
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Figure C.3 Measurement 1 B (water and CO2): Temperature inside the cell and the 
maximal intensity of the spectrum versus the time  
 
Figure C.4 Measurement 1 B (water and CO2):CO2 concentration in water and R-
value versus temperature inside the cell 
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Measurement 2 
 
Figure C.6 Measurement 2 A (water, Luvicap PL (0.6 wt. %) and CO2): Temperature 
inside the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.7 Measurement 2 A (water, Luvicap PL (0.6 wt. %) and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Figure C.8 Measurement 2 B (water, Luvicap PL (0.6 wt. %) and CO2): Temperature 
inside the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.9 Measurement 2 B (water, Luvicap PL (0.6 wt. %) and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Figure C.10 Measurement 2 C (water, Luvicap PL (0.6 wt. %) and CO2): Temperature 
inside the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.11 Measurement 2 C (water, Luvicap PL (0.6 wt. %) and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Measurement 3 
 
Figure C.12 Measurement 3 A (water, Luvicap 55W and CO2): Temperature inside 
the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.13 Measurement 3 A (water, Luvicap 55W and CO2):CO2 concentration in 
water and R-value versus temperature inside the cell 
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Figure C.14 Measurement 3 B (water, Luvicap 55W and CO2): Temperature inside 
the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.15 Measurement 3 B (water, Luvicap 55W and CO2):CO2 concentration in 
water and R-value versus temperature inside the cell 
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Figure C.16 Measurement 3 C (water, Luvicap 55W and CO2): Temperature inside 
the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.17 Measurement 3 C (water, Luvicap 55W and CO2):CO2 concentration in 
water and R-value versus temperature inside the cell 
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Measurement 4 
 
Figure C.18 Measurement 4 A (water, Luvicap PL (1 wt. %) and CO2): Temperature 
inside the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.19 Measurement 4 A (water, Luvicap PL (1 wt. %) and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Figure C.20 Measurement 4 B (water, Luvicap PL (1 wt. %) and CO2): Temperature 
inside the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.21 Measurement 4 B (water, Luvicap PL (1 wt. %) and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Figure C.22 Measurement 4 C (water, Luvicap PL (1 wt. %) and CO2): Temperature 
inside the cell and the maximal intensity of the spectrum versus the time  
 
Figure C.23 Measurement 4 C (water, Luvicap PL (1 wt. %) and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Measurement 5 
 
Figure C.24 Measurement 5 A (water, HI-M-PACT 85232 HCW and CO2): 
Temperature inside the cell and the maximal intensity of the spectrum versus the 
time  
 
Figure C.25 Measurement 5 A (water, HI-M-PACT 85232 HCW and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Figure C.26 Measurement 5 B (water, HI-M-PACT 85232 HCW and CO2): 
Temperature inside the cell and the maximal intensity of the spectrum versus the 
time  
 
Figure C.27 Measurement 5 B (water, HI-M-PACT 85232 HCW and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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Figure C.28 Measurement 5 C (water, HI-M-PACT 85232 HCW and CO2): 
Temperature inside the cell and the maximal intensity of the spectrum versus the 
time  
 
Figure C.29 Measurement 5 C (water, HI-M-PACT 85232 HCW and CO2):CO2 
concentration in water and R-value versus temperature inside the cell 
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